

Ranad Humeidi
Founder and Chief Scientific Officer at Omanta
Co-founder & CSO at Omanta, working with patients to turn frontier science into personalized treatment strategies. Harvard Chemical Biology PhD in 3 years; identified a druggable ulcerative colitis mechanism that led to a multimillion-dollar GSK collaboration. Built and directed a multimillion-dollar rare cancer program for one patient, coordinating researchers, physicians, biotechs, and drug developers. Led strategies for 12+ complex patients after standard options were exhausted.
Previously at

Omanta

Broad Institute of MIT and Harvard

Harvard University
University of Pennsylvania
Alumnus of

Harvard University